Analysts think RDHL stock price could increase by 255573%
Aug 29, 2024, 6:25 AM
22.96%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
3 analysts think RDHL stock price will increase by 255572.82%. The current median analyst target is $19380.00 compared to a current stock price of $7.58. The lowest analysts target is $19190.00 and the highest analyst target is $19950.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
